NEW YORK (GenomeWeb News) – NextGen Sciences has spun off its “gene to protein’ automation and software business to a management-led buyout group called eXeTek Ltd.
 
Ann Arbor, Mich.-based NextGen said that the divestiture is in line with its previously announced plans to either sell or wind down the automation and software business and focus its resources on growing its protein biomarker services business. The firm’s biomarker discovery and assay development service, called biomarkerexpress, was launched in November 2007.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

 Senator Lamar Alexander (R-Tenn.), who chairs the Senate health committee, will be retiring at the end of his term, Stat News reports.

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

The Wall Street Journal reports on the US Centers for Disease Control and Prevention's use of genetic approaches to study foodborne illnesses.

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.